Etablierung einer routinetauglichen PCR-Methode zur Charakterisierung genomischer PML-RARA Bruchpunkte bei pädiatrischen Patienten mit Promyelozytenleukämie
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2021
- Keyword
-
Promyelozytenleukämie
Leukämie
Patient
Retinoesäure
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2021
- Creator
- Contributor
-
Krumbholz, Manuela
Metzler, Markus
- URN
-
urn:nbn:de:bvb:29-opus4-156801
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hümmer, Eva-Maria
- Krumbholz, Manuela
- Metzler, Markus
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2021
Other Objects (12)
PML-RARA mutations confer varying arsenic trioxide resistance
![Analyse der onkogenen Eigenschaften von PML-RARα [PML-RAR-Alpha] in der akuten Promyelozyten-Leukämie](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Analyse der onkogenen Eigenschaften von PML-RARα [PML-RAR-Alpha] in der akuten Promyelozyten-Leukämie
Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides
USP22 regulates APL differentiation via PML-RARα stabilization and IFN repression
Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
Molecular methods for genomic analyses of variant PML-RARA or other RARA-related chromosomal translocations in acute promyelocytic leukemia
Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia
Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation
APL + RNAi : selektive Expressionsminderung von PML-RARα bei akuter Promyelozytenleukämie (APL) durch RNA-Interferenz (RNAi)
APL + RNAi : selektive Expressionsminderung von PML-RARα bei akuter Promyelozytenleukämie (APL) durch RNA-Interferenz (RNAi)
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia
PML-RARA mutations confer varying arsenic trioxide resistance
Analyse der onkogenen Eigenschaften von PML-RARα [PML-RAR-Alpha] in der akuten Promyelozyten-Leukämie
Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides
USP22 regulates APL differentiation via PML-RARα stabilization and IFN repression
Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
Molecular methods for genomic analyses of variant PML-RARA or other RARA-related chromosomal translocations in acute promyelocytic leukemia
Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia
Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation
APL + RNAi : selektive Expressionsminderung von PML-RARα bei akuter Promyelozytenleukämie (APL) durch RNA-Interferenz (RNAi)
APL + RNAi : selektive Expressionsminderung von PML-RARα bei akuter Promyelozytenleukämie (APL) durch RNA-Interferenz (RNAi)
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
S100A3 a partner protein regulating the stability/activity of RARα and PML-RARα in cellular models of breast/lung cancer and acute myeloid leukemia
PML-RARA mutations confer varying arsenic trioxide resistance
Analyse der onkogenen Eigenschaften von PML-RARα [PML-RAR-Alpha] in der akuten Promyelozyten-Leukämie
Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides
USP22 regulates APL differentiation via PML-RARα stabilization and IFN repression
Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
Molecular methods for genomic analyses of variant PML-RARA or other RARA-related chromosomal translocations in acute promyelocytic leukemia
Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia
Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation
APL + RNAi : selektive Expressionsminderung von PML-RARα bei akuter Promyelozytenleukämie (APL) durch RNA-Interferenz (RNAi)
APL + RNAi : selektive Expressionsminderung von PML-RARα bei akuter Promyelozytenleukämie (APL) durch RNA-Interferenz (RNAi)
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients